Purobien Lifesciences LLP - pharma in New Delhi, Delhi, India. Directors, charges & compliance details.
LLPIN AAM-4394 Incorporated 17 April 2018 ROC Delhi HQ New Delhi, Delhi, India
Converted to LLP Limited Liability Partnership pharma
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
8 yrs
Est. 2018
Employees · EPFO
33
Provident fund records
Designated partners
2
As per MCA filings
Last financials
Mar 2019
Balance sheet date
LLP status
Converted to Company
MCA master data
Registrar
Delhi
ROC office
Incorporated
17 Apr 2018
Date of incorporation

About Purobien Lifesciences LLP

Data last updated:

Purobien Lifesciences LLP was a limited liability partnership (LLP) based in New Delhi, Delhi, India. The LLP has been converted into a company and no longer exists as an LLP. For the latest details, refer to the successor company. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 April 2018.

The LLP was registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAM-4394.

The LLP had a total obligation of contribution of ₹1 Lakh. It was led by designated partners Rajesh Kumar Pandey and Vijay Kumar Aggarwal.

Its latest statement of accounts is for the year ended 31 March 2019. The registered office was at Plot No. 41 Upper Ground Floor Block – C Pocket – 9 Sector – 8 Opposite Saroj Hospital, New Delhi, Delhi, India – 110085.

The LLP has about 33 employees on its provident fund (EPFO) records.

Company details

LLPIN AAM-4394
Incorporation Date 17 April 2018
Total Obligation of Contribution ₹1 Lakh
ROC Delhi
Company Status Converted to Company

Contact details

Purobien Lifesciences LLP's registered office is in New Delhi, Delhi.

  • Registered Address
    Plot No. 41 Upper Ground Floor Block – C Pocket – 9 Sector – 8 Opposite Saroj Hospital, New Delhi, Delhi, India – 110085
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Purobien Lifesciences LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Purobien Lifesciences LLP

FY 2019 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2018-19
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2018-19
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Purobien Lifesciences LLP, buy the company report.

Designated partners of Purobien Lifesciences LLP

Purobien Lifesciences has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Designated Partners (as last reported)
NameDesignationAppointment DateTenureStatus
Rajesh Kumar PandeyDesignated Partner21 May 20197 Years 5 MonthsAs last reported
Vijay Kumar AggarwalDesignated Partner17 Apr 20188 Years 7 MonthsAs last reported

MSME payment delays

No delayed payments to MSME suppliers are on our record for Purobien Lifesciences LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Purobien Lifesciences LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Purobien Lifesciences LLP has 3 designated partner changes on record since 2018: 2 appointments and 1 cessation. The latest: Nidhi Aggarwal ceased to be Designated Partner on 21 May 2019.

Ceased
Nidhi Aggarwal ceased to be Designated Partner.
Appointed
Rajesh Kumar Pandey was appointed as Designated Partner.
AGM
Purobien Lifesciences Llp last Annual general meeting of members was held on 31 Mar 2019 as per latest MCA records.
Filing
Purobien Lifesciences Llp has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi.
Appointed
Vijay Kumar Aggarwal was appointed as Designated Partner.
Incorporation
17 Apr 2018
Purobien Lifesciences Llp was registered on 17 Apr 2018 with Roc Delhi & aged 8 years 7 months as per MCA records.

Frequently asked questions

Purobien Lifesciences has been converted into a company - the business changed its legal structure from a Limited Liability Partnership to a company. The LLP no longer exists in its previous form. For the latest information, refer to the successor company registered with MCA.

Purobien Lifesciences was a limited liability partnership based in New Delhi, Delhi, India. The LLP worked in drug formulation and development, within the pharma industry. It was incorporated on 17 April 2018 and is registered under LLPIN AAM-4394. For the latest details, refer to the successor company.

The LLPIN (Limited Liability Partnership Identification Number) of Purobien Lifesciences is AAM-4394. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Purobien Lifesciences had 2 designated partners:

Purobien Lifesciences was incorporated on 17 April 2018. It is registered with the Registrar of Companies, Delhi.

The registered office of Purobien Lifesciences is at Plot No. 41 Upper Ground Floor Block – C Pocket – 9 Sector – 8 Opposite Saroj Hospital, New Delhi, Delhi, India – 110085.

The latest financial statements of Purobien Lifesciences on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 31 March 2019. Year-wise statements from FY 2019 are in the company report.

Purobien Lifesciences operated in the pharma industry, in the drug formulation and development segment.

Nidhi Aggarwal ceased to be Designated Partner on 21 May 2019. Rajesh Kumar Pandey was appointed as Designated Partner on 21 May 2019. Vijay Kumar Aggarwal was appointed as Designated Partner on 17 Apr 2018.

Purobien Lifesciences can be reached at its registered office: Plot No. 41 Upper Ground Floor Block – C Pocket – 9 Sector – 8 Opposite Saroj Hospital, New Delhi, Delhi, India – 110085.